日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Label-Free Leukocyte Biophysical Profiling Using Impedance-Deformability Cytometry for Rapid Cardiovascular Risk Stratification

利用阻抗形变细胞术进行无标记白细胞生物物理分析以快速进行心血管风险分层

He, Linwei; Tay, Hui Min; Chen, Feng; Cheng, Hong Sheng; Wang, Liang De; Nam, Qiqi; Thannirmalai, Arunachalam; Gong, Lingyan; Chung, Aram J; Tan, Nguan Soon; Li, King Ho Holden; Dalan, Rinkoo; Wong, Siu Ling; Hou, Han Wei

Effectiveness of nirmatrelvir/ritonavir and molnupiravir on post-COVID diabetes risk among an older adult cohort: a target trial emulation study

尼马曲韦/利托那韦和莫努匹韦对老年人群新冠后糖尿病风险的影响:一项目标试验模拟研究

Guo, Zihao; Wei, Yuchen; Yang, Aimin; Wong, Carlos King Ho; Xiong, Xi; Wang, Kailu; Lin, Guozhang; Wang, Huwen; Hung, Chi Tim; Li, Conglu; Yam, Carrie Ho Kwan; Chow, Tsz Yu; Zhao, Shi; Mok, Chris Ka Pun; Hui, David S C; Yeoh, Eng Kiong; Chong, Ka Chun

Development and validation of age-specific predictive models on the risk of post-acute mortality within 1 year of COVID-19 infection

针对COVID-19感染后1年内急性期后死亡风险,开发和验证特定年龄段的预测模型

Lam, Ivan Chun Hang; Zhou, Jiayi; Liu, Wenlong; Man, Kenneth Keng Cheung; Zhang, Qingpeng; Luo, Hao; Wong, Carlos King Ho; Chui, Celine Sze Ling; Lai, Francisco Tsz Tsun; Li, Xue; Chan, Esther Wai Yin; Wong, Ian Chi Kei; Wan, Eric Yuk Fai

Greater benefits of immediate nirmatrelvir-ritonavir initiation for post-COVID outcomes: a population-based retrospective cohort study

立即启动尼马曲韦-利托那韦治疗对新冠肺炎后预后更有益:一项基于人群的回顾性队列研究

Chong, Ka Chun; Wei, Yuchen; Wong, Carlos King Ho; Xiong, Xi; Wang, Huwen; Hung, Chi Tim; Li, Conglu; Yam, Carrie Ho Kwan; Chow, Tsz Yu; Guo, Zihao; Li, Kehang; Yang, Aimin; Mok, Chris Ka Pun; Hui, David S C; Zhao, Shi; Yeoh, Eng Kiong; Lin, Guozhang

Parathyroidectomy and Risk of Incident Diabetes in Patients With Primary Hyperparathyroidism

甲状旁腺切除术与原发性甲状旁腺功能亢进患者发生糖尿病的风险

Liu, Xiaodong; Lui, David Tak Wai; Xiong, Xi; Li, Lanlan; Luk, Yan; Wong, Chun Ho; Lee, Chi Ho; Wong, Carlos King Ho; Fung, Matrix Man Him; Lang, Brian Hung Hin

Inclusion of JNK-independent drugs within multiagent chemotherapy improves response in relapsed high-risk neuroblastoma

在多药联合化疗中加入JNK非依赖性药物可提高复发性高危神经母细胞瘤的疗效。

Han, Jeremy Z R; Phimmachanh, Monica; Hastings, Jordan F; Leong, King Ho; Ng, Boaz H; Ni, Jenny; Fontaine-Titley, Angela; Cadell, Antonia L; O'Donnell, Yolande Ei; Clearwater, Misaki; Kamili, Alvin; Haber, Michelle; Norris, Murray; Timpson, Paul; Trahair, Toby N; Fletcher, Jamie I; Fey, Dirk; Kolch, Walter; Latham, Sharissa L; Croucher, David R

Benefits of glucagon-like peptide-1 receptor agonists versus pioglitazone for cardio-hepatic outcomes: a territory-wide target trial emulation

胰高血糖素样肽-1受体激动剂与吡格列酮在心肝结局方面的益处:一项区域性目标试验模拟

Li, Lanlan; Lui, David Tak-Wai; Fong, Carol Ho-Yi; Chow, Wing-Sun; Au, Ivan Chi-Ho; Xiong, Xi; Lang, Brian Hung-Hin; Wong, Carlos King-Ho; Lee, Chi-Ho

Post-pandemic excess mortality of COVID-19 in Hong Kong: a retrospective study

香港新冠疫情后超额死亡率:一项回顾性研究

Li, Kehang; Wei, Yuchen; Hung, Chi Tim; Wong, Carlos King Ho; Xiong, Xi; Chan, Paul Kay Sheung; Zhao, Shi; Guo, Zihao; Lin, Guozhang; Chi, Qiaoge; Kwan Yam, Carrie Ho; Chow, Tsz Yu; Li, Conglu; Jiang, Xiaoting; Leung, Shuk Yu; Kwok, Ka Li; Yeoh, Eng Kiong; Chong, Ka Chun

Disparate patterns of disease time burden in patients with HCC on immunotherapy or tyrosine kinase inhibitors

接受免疫疗法或酪氨酸激酶抑制剂治疗的肝细胞癌患者的疾病时间负担模式存在差异

Hui, Rex Wan-Hin; Chung, Matthew Shing-Hin; Li, Lu; Mao, Xianhua; Chiang, Chi-Leung; Wong, Carlos King-Ho; Wong, Ian Chi-Kei; Cheung, Ka-Shing; Yuen, Man-Fung; Seto, Wai-Kay; Mak, Lung-Yi

Development of a Mass-Producible Microfluidic Device for Single and Bulk Mycobacteria Investigations

用于单菌和多菌分枝杆菌研究的可大规模生产的微流控装置的开发

Teo, Adrian J T; Gu, Jianhui; Govyadinov, Alexander; Kornilovitch, Pavel; Wang, Peiyun; Goh, Serene; Tung, Nguyen Truong; Peng, Zhen; Koh, Keith; Li, King Ho Holden